SCHEMBL171183

SCHEMBL171183

Cc1cccc(-c2cn(-c3ccnc4[nH]ccc34)nc2N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 5/20 0.45
NUDT1 P36639 5/20 0.44
IKBKB O14920 2/20 0.42
CHUK O15111 2/20 0.42
CDK9 P50750 2/20 0.40
LRRK2 Q5S007 2/20 0.40
AURKB Q96GD4 2/20 0.40
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
PAK4 O96013 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
IGF1R P08069 1/20 0.40
FGFR1 P11362 1/20 0.40
PRKACA P17612 1/20 0.40
FLT1 P17948 1/20 0.40
LTK P29376 1/20 0.40
GRK5 P34947 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102275 0.84 NTRK1 (0.44) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL29540372 0.84 NTRK1 (0.44) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL29540479 0.78 MAP4K4 (0.46) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL98811 0.78 MAP4K4 (0.46) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL857101 0.77 NUDT1 (0.69) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL98273 0.77 AURKB (0.56) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL29540441 0.77 AURKB (0.56) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL18599321 0.77 LRRK2 (0.43) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL29541013 0.76 PRKCI (0.47) PRKCINUDT1IKBKBCHUKCDK9
SCHEMBL100065 0.76 PRKCI (0.47) PRKCINUDT1IKBKBCHUKCDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2474545-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2012-07-11 EP disclosed
EP-2455382-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2012-05-23 EP disclosed
EP-2426129-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2012-03-07 EP disclosed
EP-2348023-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2011-07-27 EP disclosed
EP-2343299-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2011-07-13 EP disclosed
EP-2343298-A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Incyte Corporation (US) 2011-07-13 EP disclosed